Switch theme
Sign up to access all valuation multiples
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
2016
7
Last FY Revenue n/a
LTM EBITDA -$1.1M
$15.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Neola Medical has a last 12-month revenue (LTM) of n/a and a last 12-month EBITDA of -$1.1M.
In the most recent fiscal year, Neola Medical achieved revenue of n/a and an EBITDA of -$1.0M.
Neola Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Neola Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $0.9M | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$1.1M | XXX | -$1.0M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$1.3M | XXX | -$1.1M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$1.3M | XXX | -$1.0M | XXX | XXX | XXX |
| Net Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Neola Medical's stock price is SEK 2 (or $0).
Neola Medical has current market cap of SEK 187M (or $19.3M), and EV of SEK 154M (or $15.9M).
See Neola Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15.9M | $19.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Neola Medical has market cap of $19.3M and EV of $15.9M.
Neola Medical's trades at n/a EV/Revenue multiple, and -16.7x EV/EBITDA.
Equity research analysts estimate Neola Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Neola Medical has a P/E ratio of -15.4x.
See valuation multiples for Neola Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19.3M | XXX | $19.3M | XXX | XXX | XXX |
| EV (current) | $15.9M | XXX | $15.9M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | -14.0x | XXX | -16.7x | XXX | XXX | XXX |
| EV/EBIT | -12.2x | XXX | -14.3x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | -15.4x | XXX | -18.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -7.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNeola Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.3M for the same period.
Neola Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Neola Medical's rule of X is n/a (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Neola Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Neola Medical acquired XXX companies to date.
Last acquisition by Neola Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Neola Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Neola Medical founded? | Neola Medical was founded in 2016. |
| Where is Neola Medical headquartered? | Neola Medical is headquartered in Sweden. |
| How many employees does Neola Medical have? | As of today, Neola Medical has 7 employees. |
| Is Neola Medical publicy listed? | Yes, Neola Medical is a public company listed on STO. |
| What is the stock symbol of Neola Medical? | Neola Medical trades under NEOLA ticker. |
| When did Neola Medical go public? | Neola Medical went public in 2020. |
| Who are competitors of Neola Medical? | Similar companies to Neola Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Neola Medical? | Neola Medical's current market cap is $19.3M |
| Is Neola Medical profitable? | Yes, Neola Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Neola Medical? | Neola Medical's last 12 months EBITDA is -$1.1M. |
| What is the current EV/EBITDA multiple of Neola Medical? | Current EBITDA multiple of Neola Medical is -14.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
